These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36374420)

  • 1. NMR Methods for Characterization of Glycosaminoglycan-Chemokine Interactions.
    Pomin VH; Rajarathnam K
    Methods Mol Biol; 2023; 2597():143-157. PubMed ID: 36374420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.
    Joseph PR; Mosier PD; Desai UR; Rajarathnam K
    Biochem J; 2015 Nov; 472(1):121-33. PubMed ID: 26371375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturation Transfer Difference in Characterization of Glycosaminoglycan-Protein Interactions.
    Vignovich WP; Pomin VH
    SLAS Technol; 2020 Aug; 25(4):307-319. PubMed ID: 32452261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing protein-glycosaminoglycan interactions using solution NMR spectroscopy.
    Joseph PR; Poluri KM; Sepuru KM; Rajarathnam K
    Methods Mol Biol; 2015; 1229():325-33. PubMed ID: 25325963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of chemokine interactions with heparan sulfate, chondroitin sulfate, and dermatan sulfate.
    Sepuru KM; Rajarathnam K
    J Biol Chem; 2019 Oct; 294(43):15650-15661. PubMed ID: 31455633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.
    Sepuru KM; Rajarathnam K
    J Biol Chem; 2016 Feb; 291(8):4247-55. PubMed ID: 26721883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Insights Into How Proteoglycans Determine Chemokine-CXCR1/CXCR2 Interactions: Progress and Challenges.
    Rajarathnam K; Desai UR
    Front Immunol; 2020; 11():660. PubMed ID: 32391006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions.
    Brown AJ; Joseph PR; Sawant KV; Rajarathnam K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution NMR Spectroscopy for Characterizing Protein-Glycosaminoglycan Interactions.
    Joseph PRB; Sepuru KM; Poluri KM; Rajarathnam K
    Methods Mol Biol; 2022; 2303():13-23. PubMed ID: 34626366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.
    Dyer DP; Salanga CL; Volkman BF; Kawamura T; Handel TM
    Glycobiology; 2016 Mar; 26(3):312-26. PubMed ID: 26582609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis, stoichiometry, and thermodynamics of binding of the chemokines KC and MIP2 to the glycosaminoglycan heparin.
    Sepuru KM; Nagarajan B; Desai UR; Rajarathnam K
    J Biol Chem; 2018 Nov; 293(46):17817-17828. PubMed ID: 30257866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
    Crijns H; Vanheule V; Proost P
    Front Immunol; 2020; 11():483. PubMed ID: 32296423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycan-Protein Interactions by Nuclear Magnetic Resonance (NMR) Spectroscopy.
    Pomin VH; Wang X
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30208595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR and molecular modeling reveal specificity of the interactions between CXCL14 and glycosaminoglycans.
    Penk A; Baumann L; Huster D; Samsonov SA
    Glycobiology; 2019 Sep; 29(10):715-725. PubMed ID: 31264681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chapter 4. Interactions of chemokines with glycosaminoglycans.
    Hamel DJ; Sielaff I; Proudfoot AE; Handel TM
    Methods Enzymol; 2009; 461():71-102. PubMed ID: 19480915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.
    Zhao B; Liwang PJ
    Biochemistry; 2010 Aug; 49(33):7012-22. PubMed ID: 20712376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer.
    Poluri KM; Joseph PRB; Sawant KV; Rajarathnam K
    J Biol Chem; 2013 Aug; 288(35):25143-25153. PubMed ID: 23864653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of a chemokine heterodimer binding to glycosaminoglycans.
    Sepuru KM; Rajarathnam K
    Biochem J; 2021 Mar; 478(5):1009-1021. PubMed ID: 33463672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of the viral chemokine-binding protein E163 from ectromelia virus.
    Heidarieh H; Alcamí A
    J Biol Chem; 2018 Nov; 293(45):17418-17429. PubMed ID: 30257868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.